1. Hyun SE, Lee BC, Suh BK, Chung SC, Ko CW, Kim HS, et al. Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents. Clin Biochem 2012;45:16-21.
[CROSSREF] [PUBMED]
2. Baxter RC, Binoux MA, Clemmons DR, Conover CA, Drop SL, Holly JM, et al. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology 1998;139:4036.
[CROSSREF] [PUBMED]
3. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-52.
[CROSSREF] [PUBMED]
4. Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J, et al. Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J Clin Endocrinol Metab 2014;99:1712-21.
[CROSSREF] [PUBMED]
5. Zhu H, Xu Y, Gong F, Shan G, Yang H, Xu K, et al. Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults. PLoS One 2017;12:e0185561.
[CROSSREF] [PUBMED] [PMC]
6. Romagnoli E, Minisola S, Carnevale V, Rosso R, Pacitti MT, Scarda A, et al. Circulating levels of insulin-like growth factor binding protein 3 (IGFBP-3) and insulin-like growth factor I (IGF-I) in perimenopausal women. Osteoporos Int 1994;4:305-8.
[CROSSREF] [PUBMED]
7. Dawson-Hughes B, Stern D, Goldman J, Reichlin S. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. J Clin Endocrinol Metab 1986;63:424-32.
[CROSSREF] [PUBMED]
8. Granada ML, Murillo J, Lucas A, Salinas I, Llopis MA, Castells I, et al. Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population. Eur J Endocrinol 2000;142:243-53.
[CROSSREF] [PUBMED]
9. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) 1994;41:85-93.
[CROSSREF] [PUBMED]
10. Colao A, Di Somma C, Cascella T, Pivonello R, Vitale G, Grasso LF, et al. Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol 2008;159:389-97.
[CROSSREF] [PUBMED]
11. Jehle PM, Jehle DR, Mohan S, Bohm BO. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients. J Endocrinol 1998;159:297-306.
[CROSSREF] [PUBMED]
12. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 1999;15:314-22.
[CROSSREF] [PUBMED]
13. Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 1995;80:443-9.
[CROSSREF] [PUBMED]
14. Bang P, Brismar K, Rosenfeld RG, Hall K. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. J Clin Endocrinol Metab 1994;78:960-7.
[CROSSREF] [PUBMED]
15. Hussain MA, Schmitz O, Jorgensen JO, Christiansen JS, Weeke J, Schmid C, et al. Insulin-like growth factor I alters peripheral thyroid hormone metabolism in humans: comparison with growth hormone. Eur J Endocrinol 1996;134:563-7.
[CROSSREF] [PUBMED]
16. Jorgensen JO, Moller J, Laursen T, Orskov H, Christiansen JS, Weeke J. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin Endocrinol (Oxf) 1994;41:609-14.
[CROSSREF] [PUBMED]
17. Mitchell ML, Hermos RJ, Feingold M, Moses AC. The relationship of insulin-like growth factor-I to total thyroxine in normal and low birth weight infants. Pediatr Res 1989;25:336-8.
[CROSSREF] [PUBMED]